¿ÞÂÊ ¸Þ´º ŸÀÌÆ² À̹ÌÁö
°øÁö»çÇ×

Home < ¿­¸°¸¶´ç < °øÁö»çÇ×

       2012 È£¾Ï ÀÇÇлó ¼ö»óÀÚ(Á¤Àç¿õ ¹Ú»ç) ±â³ä °­¿¬È¸ °³ÃÖ ¾È³»
               
       biodesign        2012.04.30 16:51        6863
 
1. ¼ö»óÀÚ/°­¿¬ÀÚ: Á¤Àç¿õ ¹Ú»ç (Ú¸ ³²°¡ÁÖ´ë KECK ÀÇ´ë ±³¼ö, KAIST »ý¸í°úÇаú °âÀÓ±³¼ö) 2. ÀϽÃ: 2012. 5. 2 (¼ö) ¿ÀÈÄ 4½Ã 3. Àå¼Ò: KAIST KIºôµù(E4) 1Ãþ Ç»ÀüȦ 4. ÁÖÃÖ: KAIST »ý¸í°úÇаú, KI ¹ÙÀÌ¿ÀÀ¶ÇÕ¿¬±¸¼Ò, ISBC ±Û·Î¹úÇÁ·ÐƼ¾î ¿¬±¸´Ü, KAIST-USC ±Û·Î¹ú¿¬±¸¼Ò, È£¾ÏÀç´Ü * °­¿¬ Á¦¸ñ ¹× ÃÊ·Ï Host-Pathogen Standoff: Roles of Pattern Recognizing Receptors and Intracellular Restriction Factors in Antiviral Immune Response Understanding the host-viral interaction is an essential step in developing safe and effective anti-microbials against viruses. Since virus is most vulnerable at the early stage of lifecycle, this stage should therefore offer the best opportunity for therapeutic interventions. The early detection of invading viruses by the host depends on a limited number of Pattern Recognizing Receptors (PRRs) that serve as the primary intracellular sensors for viral specific genetic patterns and activate signal transduction cascades, thereby triggering interferon (IFN)-mediated antiviral defense mechanisms. Key virus-detecting PRRs include the nucleic acid-recognizing Toll-like receptors and the cytosolic RNA receptors RIG-I and MDA-5. Specifically, RIG-I has emerged as a key receptor in sensing viruses, including the influenza virus and hepatitis virus C (HCV), whereas MDA5 responds to the infection of picornaviruses and noroviruses. Upon viral infection, RIG-I undergoes the multiple step processes of ATP-dependent structural and functional activations to elicit IFN-mediated antiviral signal transduction. In addition, members of the tripartite motif (TRIM) proteins and the Linear Ubiquitination Assembly Complex (LUBAC) proteins also play major roles in the IFN-mediated inhibition of the lifecycles of viruses. Following the PRR-mediated viral sensing, hosts subsequently elicit intracellular



Total:66 page:(5/3)
34 Á¤º¸ biodesig (Àç) Áö´ÉÇü ¹ÙÀÌ¿À ½Ã½ºÅÛ ¼³°è ¹× ÇÕ¼º ¿¬±¸´Ü .. 17.09.06 6916
33 Á¤º¸ biodesig (Àç) Áö´ÉÇü ¹ÙÀÌ¿À ½Ã½ºÅÛ ¼³°è ¹× ÇÕ¼º ¿¬±¸´Ü .. 17.05.26 7385
32 Á¤º¸ ISBC (Àç)¹ÙÀÌ¿ÀÇÕ¼º¿¬±¸´Ü ¿¬±¸Áö¿øº»ºÎÀå ä¿ë Àç°ø.. 16.11.04 7402
31 Á¤º¸ ISBC (Àç)¹ÙÀÌ¿ÀÇÕ¼º¿¬±¸´Ü ¿¬±¸Áö¿øº»ºÎÀå ä¿ë °ø°í 16.10.17 7873
30 Á¤º¸ biodesig (Àç)¹ÙÀÌ¿ÀÇÕ¼º¿¬±¸´Ü ¼º°úÀü½Ãȸ¿¡ ÃÊ´ë ÇÕ´Ï´Ù 16.06.10 9749
29 Á¤º¸ biodesig (Àç)¹ÙÀÌ¿ÀÇÕ¼º ¿¬±¸´Ü ¿¬±¸¿ø ¸ðÁý °ø°í 16.02.22 9219
28 Á¤º¸ ISBC [Ãʺù°ø°í] Áö´ÉÇü ¹ÙÀÌ¿À½Ã½ºÅÛ ¼³°è ¹× ÇÕ¼º ¿¬.. 16.01.26 8647
27 Á¤º¸ ISBC [½Å±Ô°úÁ¦] Áö´ÉÇü ¹ÙÀÌ¿À½Ã½ºÅÛ ¼³°è ¹× ÇÕ¼º ¿¬.. 15.06.23 9386
26 Á¤º¸ ISBC ¿¬±¸´Ü ¿¬±¸¿ø ä¿ë ÀÔ»çÁö¿ø¼­ 15.06.22 8088
25 Á¤º¸ ISBC (Àç)¹ÙÀÌ¿ÀÇÕ¼º¿¬±¸´Ü ¿¬±¸¿ø »ó½Ãä¿ë °ø°í 14.09.19 9467
24 Á¤º¸ ISBC (Àç)¹ÙÀÌ¿ÀÇÕ¼º ¿¬±¸´Ü ¿¬±¸¿ø ¸ðÁý °ø°í 14.09.11 8362
23 Á¤º¸ ISBC (Àç)¹ÙÀÌ¿ÀÇÕ¼º ¿¬±¸´Ü ¿¬±¸¿ø ¸ðÁý °ø°í 14.08.08 8124
22 Á¤º¸ ISBC [½Å±Ô°úÁ¦°ø°í] (Àç)¹ÙÀÌ¿ÀÇÕ¼º¿¬±¸´Ü 2´Ü°è 2Â÷.. 14.07.10 7188
21 Á¤º¸ ISBC [Á÷¿ø°ø°í] (Àç)¹ÙÀÌ¿ÀÇÕ¼º¿¬±¸´Ü ¿¬±¸¿ø ¸ðÁý °ø.. 14.04.22 8168
20 Á¤º¸ ISBC [Á÷¿ø°ø°í] (Àç)¹ÙÀÌ¿ÀÇÕ¼º¿¬±¸´Ü Á÷¿ø ¸ðÁý °ø°í 14.04.18 8760
19 Á¤º¸ biodesig [¹ÙÀÌ¿ÀÇÕ¼º¿¬±¸´Ü] Áß°£Á¡°Ë ¿öÅ©¼ó ¾È³» 14.03.04 8289
[1] [2] [3] [4] [5]